default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

Hana Pharm to go public next month

기사승인 2018.09.07  06:22:10

공유
default_news_ad2

Hana Pharm Co., a South Korean pharmaceutical firm, said Thursday it plans to go public on the country's main bourse next month to raise funds for facility investment to further advance its overseas market presence.

Hana Pharm will offer 4.08 million shares at a price band between 24,500 won and 28,000 won, which will allow the firm to raise up to 114.3 billion won (US$101.69 million), according to the company.

Lee Yun-ha, chief of Hana Pharm Co. (Yonhap)

The IPO price will be fixed later this month, and its market debut is expected to be made in early October, although the exact date hasn't been fixed, the company said, adding that its market capitalization is expected to reach as much as 450 billion won.

Mirae Asset Daewoo Co. is in charge of the IPO procedures.

"This will help us build our third factory that meets European standards so as to strengthen our market position in both domestic and global arenas," the drugmaker said.

Established in 1996, Hana Pharm has specialized in anesthetic and narcotic analgesics. Last year, it reported 139.3 billion won in sales, up 11 percent from the previous year, and 31.9 billion won of operating profits, which was a 35 percent increase on-year. (Yonhap)

Cho Kyung-hee edt@koreapost.com

<저작권자 © 코리아포스트 무단전재 및 재배포금지>
default_news_ad5
default_side_ad1
default_nd_ad2

인기기사

default_side_ad2

포토

1 2 3
set_P1
default_side_ad3

섹션별 인기기사 및 최근기사

default_side_ad4
default_nd_ad6
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch